Practice parameters in management of status epileptics

Area of Science:

• Neurology
• Emergency Medicine
• Global Health

Background:

• Status epilepticus (SE) is a critical neurological emergency.
• SE incidence is higher in developing nations due to factors like infection, stroke, and head injury.
• Current SE management protocols may be challenging in resource-limited settings.

Purpose of the Study:

• To review the limitations of existing SE management guidelines in developing countries.
• To suggest alternative antiepileptic drugs (AEDs) suitable for resource-poor settings.
• To address the safety concerns of current SE treatments in contexts with limited intensive care.

Main Methods:

• Literature review focusing on SE management protocols.
• Analysis of antiepileptic drug (AED) toxicity profiles, particularly cardiovascular and respiratory effects.
• Evaluation of treatment options in the context of developing countries' healthcare infrastructure.

Main Results:

• Standard SE protocols often rely on intravenous benzodiazepines, phenytoin, valproate (VPA), phenobarbitone, and general anesthesia (GA).
• General anesthesia (GA) poses risks like hypotension and respiratory depression, requiring intensive care.
• Limited intensive care facilities in developing countries restrict the safe use of certain AEDs due to their inherent toxicities.

Conclusions:

• Existing SE guidelines may not be optimal for resource-poor countries.
• Valproate (VPA), levetiracetam, and lacosamide show promise for SE management due to their safety profiles.
• Further evaluation of these AEDs is recommended for SE treatment in developing nations.